Messages in brief
Medicinal Products Import Act 2010 - Forms
The Medicinal Products Import Act 2010, BGBl I 79/2010, came into force on 19.08.2010.
Compilation of the scenarios possible according to the law…
Medicinal Products Import Act 2010 (AWEG)
On 18.08.2010, the Medicinal Products Import Act 2010 was published in the Federal Law Gazette, Federal Law Gazette I No. 79/2010 and comes into force…
Statement on "Calcium Substitution and Myocardial Infarction Risk."
The Federal Office for Safety in Health Care (BASG) publishes the following statement on "Calcium Supplementation and Myocardial Infarction Risk." It…
Guideline for the implementation of non-interventional studies
Further information:Download guide
Campaign on children's medicines
Children's health depends to a large extent on the availability of appropriate medicines. Half of the medicines used to treat 100 million children and…
NIS regulation in force as of 01.09.2010
In Federal Law Gazette II No. 180/2010, the Federal Minister of Health made use of the power to issue an ordinance pursuant to Section 48 (3) AMG and…
Risks associated with supports and support arms
The Federal Office for Safety in Health Care (BASG) / AGES PharmMed provides information on holders and carrier arms.
Wall mountsAuser in Austria…
Questionnaire for the implementation of the Medical Device Operator V
According to § 68 of the Medical Devices Act (MPG), Federal Law Gazette No. 657/1996, last amended by Federal Law Gazette I No. 143/2009, the Federal…
No restriction of Rotarix and Rotateq
On March 17, 2010, the marketing authorization holder (GlaxoSmithKline Biologicals, GSK) informed the European Medicines Agency (EMA) that the oral…
Cancellation of marketing authorization for bufexamac-containing proprietary medicinal products
Based on a re-evaluation of the safety and efficacy data, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
